| Antimicrobial activity of the metals and metal oxide nanoparticles SM Dizaj, F Lotfipour, M Barzegar-Jalali, MH Zarrintan, K Adibkia Materials Science and Engineering: C 44, 278-284, 2014 | 1693 | 2014 |
| The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts A Nokhodchi, Y Javadzadeh, MR Siahi-Shadbad, M Barzegar-Jalali Journal of Pharmacy and pharmaceutical Sciences 8 (1), 18-25, 2005 | 379 | 2005 |
| Kinetic analysis of drug release from nanoparticles M Barzegar-Jalali Journal of Pharmacy & Pharmaceutical Sciences 11 (1), 167-177, 2008 | 369 | 2008 |
| Calcium carbonate nanoparticles as cancer drug delivery system S Maleki Dizaj, M Barzegar-Jalali, MH Zarrintan, K Adibkia, F Lotfipour Expert opinion on drug delivery 12 (10), 1649-1660, 2015 | 294 | 2015 |
| Predicting human intestinal permeability using single-pass intestinal perfusion in rat P Zakeri-Milani, H Valizadeh, H Tajerzadeh, Y Azarmi, Z Islambolchilar, ... Journal of Pharmacy and Pharmaceutical Sciences 10 (3), 368-379, 2007 | 259 | 2007 |
| Enhancement of dissolution rate of piroxicam using liquisolid compacts Y Javadzadeh, MR Siahi-Shadbad, M Barzegar-Jalali, A Nokhodchi Il Farmaco 60 (4), 361-365, 2005 | 250 | 2005 |
| Comparison of various cosolvency models for calculating solute solubility in water–cosolvent mixtures A Jouyban-Gharamaleki, L Valaee, M Barzegar-Jalali, BJ Clark, ... International journal of pharmaceutics 177 (1), 93-101, 1999 | 241 | 1999 |
| The enhancement effect of surfactants on the penetration of lorazepam through rat skin A Nokhodchi, J Shokri, A Dashbolaghi, D Hassan-Zadeh, T Ghafourian, ... International Journal of Pharmaceutics 250 (2), 359-369, 2003 | 223 | 2003 |
| The effect of surfactants on the skin penetration of diazepam J Shokri, A Nokhodchi, A Dashbolaghi, D Hassan-Zadeh, T Ghafourian, ... International Journal of Pharmaceutics 228 (1-2), 99-107, 2001 | 208 | 2001 |
| Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles S Salatin, J Barar, M Barzegar-Jalali, K Adibkia, F Kiafar, M Jelvehgari Research in pharmaceutical sciences 12 (1), 1-14, 2017 | 188 | 2017 |
| Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis K Adibkia, MRS Shadbad, A Nokhodchi, A Javadzedeh, M Barzegar-Jalali, ... Journal of drug targeting 15 (6), 407-416, 2007 | 188 | 2007 |
| Development of azithromycin–PLGA nanoparticles: Physicochemical characterization and antibacterial effect against Salmonella typhi G Mohammadi, H Valizadeh, M Barzegar-Jalali, F Lotfipour, K Adibkia, ... Colloids and Surfaces B: Biointerfaces 80 (1), 34-39, 2010 | 178 | 2010 |
| Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability P Zakeri-Milani, M Barzegar-Jalali, M Azimi, H Valizadeh European journal of pharmaceutics and biopharmaceutics 73 (1), 102-106, 2009 | 169 | 2009 |
| Changes in the faecal microbiota of mares precede the development of post partum colic JS Weese, SJ Holcombe, RM Embertson, KA Kurtz, HA Roessner, ... Equine veterinary journal 47 (6), 641-649, 2015 | 162 | 2015 |
| Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation P Zakeri-Milani, M Barzegar-Jalali, H Tajerzadeh, Y Azarmi, H Valizadeh Journal of pharmaceutical and biomedical analysis 39 (3-4), 624-630, 2005 | 156 | 2005 |
| A general model from theoretical cosolvency models M Barzegar-Jalali, A Jouyban-Gharamaleki International journal of pharmaceutics 152 (2), 247-250, 1997 | 156 | 1997 |
| Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits K Adibkia, Y Omidi, MR Siahi, AR Javadzadeh, M Barzegar-Jalali, J Barar, ... Journal of Ocular Pharmacology and Therapeutics 23 (5), 421-432, 2007 | 139 | 2007 |
| Polyester based polymeric nano and microparticles for pharmaceutical purposes: A review on formulation approaches F Molavi, M Barzegar-Jalali, H Hamishehkar Journal of Controlled Release 320, 265-282, 2020 | 138 | 2020 |
| Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c … MA Danesh-Bahreini, J Shokri, A Samiei, E Kamali-Sarvestani, ... International Journal of nanomedicine, 835-842, 2011 | 137 | 2011 |
| Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide) M Barzegar-Jalali, H Valizadeh, MRS Shadbad, K Adibkia, G Mohammadi, ... Powder Technology 197 (3), 150-158, 2010 | 137 | 2010 |
Khosro AdibkiaProfessor of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, IranVerified email at tbzmed.ac.ir
